Annual EBITDA
-$133.82M$148.55M+52.61%
Summary
- Current Value
- As of today, ASND annual EBITDA is -$133.82M, up +52.61% on
- Historical Performance
- ASND annual EBITDA is up +76.59% over the past 3 years, up +63.45% over the past 5 years
- All-Time High Comparison
- ASND annual EBITDA is currently -1873.36% below its historical high of $7.55M set on
- 3-Year Low Comparison
- ASND annual EBITDA is +76.59% above its 3-year low of -$571.58M reached on an earlier date
- Sector Comparison
- ASND annual EBITDA is higher than 12.87% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$133.82M | +52.6% | +76.6% | +63.5% | – | |
| Quarterly EBITDA | $77.86M | +241.2% | +152.5% | +156.7% | – | |
| TTM EBITDA | $146.51M | +157.2% | +125.1% | +130.3% | – | |
| Price | $248.50 | +29.4% | +169.5% | +105.4% | – | |
| PE Ratio | 28.01 | – | – | – | – | |
| Annual Revenue | $812.73M | +106.6% | +1411.1% | +10000.0% | – | |
| Annual EPS | -$4.25 | +39.9% | +61.1% | +55.0% | – | |
| -$153.79M | +49.0% | +74.0% | +59.2% | – | ||
| Annual Net Income | -$257.35M | +37.1% | +58.0% | +46.1% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$133.82M | at high | |
| 5Y | -$133.82M | at high | |
| All | $7.55M | -1873.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$571.58M | N/A | +76.6% |
| 5Y | -$571.58M | +76.6% | |
| All | -$571.58M | +76.6% |
EBITDA History
FAQ
- What is the current annual EBITDA of ASND?
- As of today, ASND annual EBITDA is -$133.82M
- What is 1-year change in ASND annual EBITDA?
- ASND annual EBITDA is up +52.61% year-over-year
- What is 3-year change in ASND annual EBITDA?
- ASND annual EBITDA is up +76.59% over the past 3 years
- How far is ASND annual EBITDA from its all-time high?
- ASND annual EBITDA is currently -1873.36% below its historical high of $7.55M set on December 31, 2013
- How does ASND annual EBITDA rank versus sector peers?
- ASND annual EBITDA is higher than 12.87% of companies in Healthcare sector
- When is ASND next annual earnings release?
- As of today, the next annual earnings release for ASND has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$77.86M$43.90M+129.24%
Summary
- Current Value
- As of today, ASND quarterly EBITDA is $77.86M, up +129.24% on
- Historical Performance
- ASND quarterly EBITDA is up +241.22% year-over-year, up +152.53% over the past 3 years
- All-Time High Comparison
- ASND quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ASND quarterly EBITDA is +152.53% above its 3-year low of -$148.22M reached on an earlier date
- Sector Comparison
- ASND quarterly EBITDA is higher than 86.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $77.86M | +129.2% | +241.2% | +152.5% | +156.7% | |
| Annual EBITDA | -$133.82M | – | +52.6% | +76.6% | +63.5% | |
| TTM EBITDA | $146.51M | +984.3% | +157.2% | +125.1% | +130.3% | |
| Price | $248.50 | +1.2% | +29.4% | +169.5% | +105.4% | |
| PE Ratio | 28.01 | +1.2% | – | – | – | |
| Quarterly Revenue | $394.49M | +36.7% | +120.2% | +664.8% | +10000.0% | |
| Quarterly EPS | $3.52 | -69.1% | +583.5% | +249.8% | +217.1% | |
| $267.53M | +821.6% | +545.8% | +274.5% | +288.6% | ||
| Quarterly Net Income | $240.65M | -67.3% | +646.4% | +282.1% | +248.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $77.86M | at high | |
| 3Y | $77.86M | at high | |
| 5Y | $77.86M | at high | |
| All | $77.86M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$55.13M | N/A | +241.2% |
| 3Y | -$148.22M | N/A | +152.5% |
| 5Y | -$149.29M | +152.2% | |
| All | -$149.29M | +152.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ASND?
- As of today, ASND quarterly EBITDA is $77.86M
- What is ASND quarterly EBITDA most recent change?
- ASND quarterly EBITDA was up +129.24% on June 1, 2026
- What is 1-year change in ASND quarterly EBITDA?
- ASND quarterly EBITDA is up +241.22% year-over-year
- How far is ASND quarterly EBITDA from its all-time high?
- ASND quarterly EBITDA is currently at its all-time high
- How does ASND quarterly EBITDA rank versus sector peers?
- ASND quarterly EBITDA is higher than 86.30% of companies in Healthcare sector
- When is ASND next earnings release?
- As of today, the next earnings release for ASND has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$146.51M$133.00M+984.29%
Summary
- Current Value
- As of today, ASND TTM EBITDA is $146.51M, up +984.29% on
- Historical Performance
- ASND TTM EBITDA is up +157.16% year-over-year, up +125.08% over the past 3 years
- All-Time High Comparison
- ASND TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ASND TTM EBITDA is +125.08% above its 3-year low of -$584.18M reached on
- Sector Comparison
- ASND TTM EBITDA is higher than 83.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $146.51M | +984.3% | +157.2% | +125.1% | +130.3% | |
| Annual EBITDA | -$133.82M | – | +52.6% | +76.6% | +63.5% | |
| Quarterly EBITDA | $77.86M | +129.2% | +241.2% | +152.5% | +156.7% | |
| Price | $248.50 | +1.2% | +29.4% | +169.5% | +105.4% | |
| PE Ratio | 28.01 | +1.2% | – | – | – | |
| TTM Revenue | $1.22B | +21.4% | +128.4% | +866.0% | +10000.0% | |
| TTM EPS | $13.12 | +47.9% | +364.2% | +216.2% | +228.7% | |
| $320.93M | +4948.2% | +216.5% | +153.2% | +164.4% | ||
| TTM Net Income | $866.59M | +48.9% | +395.1% | +236.9% | +258.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $146.51M | at high | |
| 3Y | $146.51M | at high | |
| 5Y | $146.51M | at high | |
| All | $146.51M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$256.32M | N/A | +157.2% |
| 3Y | -$584.18M | +125.1% | |
| 5Y | -$584.18M | +125.1% | |
| All | -$584.18M | +125.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ASND?
- As of today, ASND TTM EBITDA is $146.51M
- What is ASND TTM EBITDA most recent change?
- ASND TTM EBITDA was up +984.29% on June 1, 2026
- What is 1-year change in ASND TTM EBITDA?
- ASND TTM EBITDA is up +157.16% year-over-year
- How far is ASND TTM EBITDA from its all-time high?
- ASND TTM EBITDA is currently at its all-time high
- How does ASND TTM EBITDA rank versus sector peers?
- ASND TTM EBITDA is higher than 83.92% of companies in Healthcare sector
- When is ASND next earnings release?
- As of today, the next earnings release for ASND has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ASND Official Website ascendispharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612042/000119312526046590/0001193125-26-046590-index.htm
- ASND Profile on Yahoo Finance finance.yahoo.com/quote/ASND
- ASND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/asnd